spacer
The Healthcare Sales & Marketing Network celebrates 27 years serving the medical sales & marketing community.Connecting Medical Independent Sales Reps and Distributors with Manufacturers and New Product LinesConnecting Medical Independent Sales Reps and Distributors with Manufacturers and New Product Lines

Healthcare News Roundup: Biopharmaceutical

 HSMN NewsFeed - 8 Jan 2026
Seasoned Biotherapeutics Leader Thomas J. Farrell Joins NanoSyrinx as CEO to Advance Nanosyringe-enabled Intracellular Medicines
Biopharmaceuticals Drug Delivery Personnel
 HSMN NewsFeed - 7 Jan 2026
Mediar Therapeutics Announces Oversubscribed $76 Million Series B Financing and Clinical Advancement of First-in-Class Fibrosis Portfolio
Biopharmaceuticals Venture Capital
 HSMN NewsFeed - 5 Jan 2026
ScinoPharm Secures U.S. FDA Approval for Glatiramer Acetate Injection for the Treatment of Multiple Sclerosis
Biopharmaceuticals Generics Neurology FDA
 HSMN NewsFeed - 29 Dec 2025
FDA Accepts for Review INOVIO's BLA for INO-3107 for the Treatment of Adults with Recurrent Respiratory Papillomatosis (RRP)
Biopharmaceuticals FDA
 HSMN NewsFeed - 24 Dec 2025
Sanofi to Acquire Dynavax, Adding a Marketed Adult Hepatitis B Vaccine and Phase 1/2 Shingles Candidate to the Pipeline
Biopharmaceuticals Mergers & Acquisitions
 HSMN NewsFeed - 23 Dec 2025
Zydus Partners with Bioeq for U.S. Commercialisation rights for NUFYMCO(R), an Interchangeable Biosimilar to Lucentis(R)
Biopharmaceuticals Licensing
 HSMN NewsFeed - 22 Dec 2025
U.S. FDA Approves JASCAYD(R) (nerandomilast) Tablets for the Treatment of Progressive Pulmonary Fibrosis in Adults
Biopharmaceuticals FDA
 HSMN NewsFeed - 19 Dec 2025
BioMarin to Acquire Amicus Therapeutics for $4.8 Billion, Expanding Position as a Leader in Rare Diseases, Accelerating Revenue Growth and Strengthening Financial Outlook
Biopharmaceuticals Mergers & Acquisitions
 HSMN NewsFeed - 15 Dec 2025
Sobi to Acquire Arthrosi Therapeutics, Strengthening Pipeline for the Potential Treatment of Gout
Biopharmaceuticals Mergers & Acquisitions
 HSMN NewsFeed - 12 Dec 2025
Alphyn Closes $25M Oversubscribed Series B Financing Round to Advance Dermatology Pipeline
Biopharmaceuticals Dermatology Venture Capital
 HSMN NewsFeed - 10 Dec 2025
Expression Therapeutics Appoints Industry Veteran Dr. David Townson as Chief Executive Officer
Biopharmaceuticals Personnel
 HSMN NewsFeed - 9 Dec 2025
Mercury Bio Announces Appointment of Casey Perkins as Vice President of Corporate Strategy & Business Development
Biopharmaceuticals Drug Delivery Personnel
 HSMN NewsFeed - 4 Dec 2025
SciNeuro Pharmaceuticals Announces $53 Million Financing to Further Advance Pipeline of Therapies for Neurodegenerative Diseases and Appointment of Chief Financial Officer
Biopharmaceuticals Neurology Venture Capital
 HSMN NewsFeed - 28 Nov 2025
Vanda Pharmaceuticals Provides Regulatory Update on Tradipitant for Motion Sickness
Biopharmaceuticals FDA
Older Biopharmaceutical stories   Return to NewsFeed  
FindReps - Find Great Medical Independent Sales Reps without recruiter fees.
FindReps - available on the Apple App Store for iPhone and iPad.